NCT00257855View on ClinicalTrials.gov

A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

January 31, 2009

Study Completion Date

February 28, 2009

Conditions
Secondary Progressive Multiple Sclerosis
Interventions
DRUG

Lamotrigine

Trial Locations (1)

WC1 3BG

National Hospital for Neurology and Neurosurgery, London

All Listed Sponsors
lead

University College London Hospitals

OTHER

NCT00257855 - A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis | Biotech Hunter | Biotech Hunter